WH [PUblic Domain]
The drug company Gilead is touting positive data on a study of a possible treatment for COVID-19.
According to The Hill:
Gilead Sciences said Wednesday it is aware of “positive data” emerging from a clinical trial studying one of its drugs as a potential treatment for COVID-19.
The National Institute of Allergy and Infectious Diseases’s study of remdesivir, an experimental antiviral, has reached its primary endpoint, Gilead said, meaning the drug was found to be effective in the trial.
The institute, which is headed by Anthony Fauci, a key member of the White House’s coronavirus task force, is expected to release more information Wednesday, Gilead said.
There is no proven COVID-19 treatment yet, though hundreds of clinical trials are ongoing all around the world to find one. Scientists have high hopes for remdesivir, which was originally developed as a potential treatment for Ebola, but was found to be ineffective.
Former FDA Commissioner Scott Gottlieb said the drug is likely not a home run but will help in the battle against the worsening effects of the virus.